TG治疗公司

最新新闻

• 评级变动
  TD Cowen Maintains TG Therapeutics(TGTX.US) With Buy Rating, Maintains Target Price $75
  \u5e02\u573a\u8d44\u8baf · 2026/8/4
• H.C. Wainwright Maintains TG Therapeutics(TGTX.US) With Buy Rating, Maintains Target Price $78
  \u5e02\u573a\u8d44\u8baf · 2026/9/22
• J.P. Morgan Maintains TG Therapeutics(TGTX.US) With Buy Rating, Raises Target Price to $72
  \u5e02\u573a\u8d44\u8baf · 2026/8/11
• B. Riley Securities Maintains TG Therapeutics(TGTX.US) With Buy Rating, Raises Target Price to $86
  \u5e02\u573a\u8d44\u8baf · 2026/9/2
• 评级变动
  Goldman Sachs Maintains TG Therapeutics(TGTX.US) With Hold Rating, Raises Target Price to $41
  \u5e02\u573a\u8d44\u8baf · 2026/5/28
• 评级变动
  BofA Securities Maintains TG Therapeutics(TGTX.US) With Sell Rating, Raises Target Price to $17
  \u5e02\u573a\u8d44\u8baf · 2026/6/4
• 评级变动
  H.C. Wainwright Maintains TG Therapeutics(TGTX.US) With Buy Rating, Maintains Target Price $70
  \u5e02\u573a\u8d44\u8baf · 2026/7/6
• 评级变动
  H.C. Wainwright Maintains TG Therapeutics(TGTX.US) With Buy Rating, Raises Target Price to $78
  \u5e02\u573a\u8d44\u8baf · 2026/8/4
• 评级变动
  Jefferies Maintains TG Therapeutics(TGTX.US) With Buy Rating, Maintains Target Price $83
  \u5e02\u573a\u8d44\u8baf · 2026/7/14
• 评级变动
  J.P. Morgan Maintains TG Therapeutics(TGTX.US) With Buy Rating
  \u5e02\u573a\u8d44\u8baf · 2026/5/28
• 评级变动
  TG Therapeutics (TGTX) Gets a Buy From H.C. Wainwright
  TipRanks · 2026/7/13
• 评级变动
  BofA Securities Maintains TG Therapeutics(TGTX.US) With Sell Rating, Raises Target Price to $21
  \u5e02\u573a\u8d44\u8baf · 2026/8/5
• 评级变动
  TD Cowen Maintains TG Therapeutics(TGTX.US) With Buy Rating, Raises Target Price to $75
  \u5e02\u573a\u8d44\u8baf · 2026/7/22
• TG Therapeutics (TGTX) Receives a Buy From H.C. Wainwright
  TipRanks · 2026/9/22
• 评级变动
  Jefferies Maintains TG Therapeutics(TGTX.US) With Buy Rating, Raises Target Price to $83
  \u5e02\u573a\u8d44\u8baf · 2026/6/23
• 评级变动
  Goldman Sachs Maintains TG Therapeutics(TGTX.US) With Hold Rating, Maintains Target Price $41
  \u5e02\u573a\u8d44\u8baf · 2026/6/4
• B. Riley Securities Remains a Buy on TG Therapeutics (TGTX)
  TipRanks · 2026/9/2
• 评级变动
  BofA Securities Maintains TG Therapeutics(TGTX.US) With Sell Rating, Raises Target Price to $20
  \u5e02\u573a\u8d44\u8baf · 2026/7/7
• 评级变动
  H.C. Wainwright Maintains TG Therapeutics(TGTX.US) With Buy Rating, Raises Target Price to $77
  \u5e02\u573a\u8d44\u8baf · 2026/7/13
• 评级变动
  J.P. Morgan Maintains TG Therapeutics(TGTX.US) With Buy Rating, Announces Target Price $65
  \u5e02\u573a\u8d44\u8baf · 2026/7/16

新闻标题为自动聚合内容，未经我们团队独立核实或编辑。